The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

According to CMS estimates, passage of the rule would open access to the weight-loss medications to 3.4 million potential new ...

CNBC's Bertha Coombs joins 'Squawk on the Street' to report on Biden's administration plan to expand coverage of GLP-1 drugs ...

Piper Sandler's Christopher Raymond joins 'Fast Money' to talk Amgen's stock sinking on GLP-1 results. Kamala Harris ...

GLP-1 medications like Ozempic and Wegovy are shielding the kidneys from harm, even as they help ease diabetes and obesity.

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.

Allurion's new program uses artificial intelligence guidance to help patients adhere to a well-rounded diet and exercise ...